---
kind: "section"
citation: "42 U.S.C. § 285b–1"
title: "42"
title_heading: "The Public Health and Welfare"
number: "285b–1"
heading: "Heart, blood vessel, lung, and blood disease prevention and control programs"
release: "119-102"
date: "2026-07-12"
url: "https://uscodex.org/usc/42/285b-1"
units:
  - "Chapter 6A — Public Health Service"
  - "Subchapter III — National Research Institutes"
  - "Part C — Specific Provisions Respecting National Research Institutes"
  - "Subpart 2 — national heart, lung, and blood institute"
---

# §285b–1. Heart, blood vessel, lung, and blood disease prevention and control programs

- (a) The [Director](/usc/42/11851.md?p=5) of the Institute shall conduct and support [programs](/usc/42/274l–1.md?p=4) for the prevention and control of heart, blood [vessel](/usc/42/201.md?p=i), lung, and blood diseases. Such [programs](/usc/42/274l–1.md?p=4) shall include community-based and population-based [programs](/usc/42/274l–1.md?p=4) carried out in cooperation with other Federal [agencies](/usc/42/8262.md?p=1), with public health [agencies](/usc/42/8262.md?p=1) of [State](/usc/42/201.md?p=f) or local governments, with [nonprofit](/usc/42/300s–3.md?p=3) private entities that are community-based health [agencies](/usc/42/8262.md?p=1), or with other appropriate public or [nonprofit](/usc/42/300s–3.md?p=3) private entities.
- (b) In carrying out [programs](/usc/42/274l–1.md?p=4) under [subsection (a)](#a), the [Director](/usc/42/11851.md?p=5) of the Institute shall give special consideration to the prevention and control of heart, blood [vessel](/usc/42/201.md?p=i), lung, and blood diseases in children, and in populations that are at increased risk with respect to such diseases.

## Source credit

(July 1, 1944, ch. 373, title IV, § 419, as added Pub. L. 99–158, § 2, Nov. 20, 1985, 99 Stat. 836; amended Pub. L. 103–43, title V, § 505, June 10, 1993, 107 Stat. 160.)

## Notes

### Editorial Notes

### Amendments

1993—Pub. L. 103–43 substituted subsecs. (a) and (b) for former section which read as follows: “The Director of the Institute, under policies established by the Director of NIH and after consultation with the advisory council for the Institute, shall establish programs as necessary for cooperation with other Federal health agencies, State, local, and regional public health agencies, and nonprofit private health agencies in the diagnosis, prevention, and treatment (including the provision of emergency medical services) of heart, blood vessel, lung, and blood diseases, appropriately emphasizing the prevention, diagnosis, and treatment of such diseases of children.”